Page last updated: 2024-08-17

medroxyprogesterone acetate and Bright Disease

medroxyprogesterone acetate has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alpers, CE; Clark, EA; Elkon, KB; Hudkins, KL; Hughes, GC; Martin, D; Zhang, K	1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Bright Disease

Article	Year
Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice. Arthritis and rheumatism, 2009, Volume: 60, Issue:6 Topics: Animals; Autoantibodies; B7-2 Antigen; Complement C3; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Progesterone; Proteinuria; Th1 Cells	2009

Article

Year

Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.

Arthritis and rheumatism, 2009, Volume: 60, Issue:6

Topics: Animals; Autoantibodies; B7-2 Antigen; Complement C3; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Progesterone; Proteinuria; Th1 Cells

2009